Mwandishi:
ULY CLINIC
Mhariri:
ULY CLINIC
Imeboreshwa;
22 Mei 2026, 03:20:06
Megaloblastic Anemia
Megaloblastic anemia is a macrocytic anemia characterized by ineffective erythropoiesis and the presence of large, structurally abnormal, immature red blood cell precursors (megaloblasts) in the bone marrow.
It is most commonly caused by:
Vitamin B12 (cobalamin) deficiency
Folate (vitamin B9) deficiency
Both vitamins are essential for DNA synthesis, and their deficiency results in defective nuclear maturation with preserved cytoplasmic development (nuclear–cytoplasmic asynchrony).
Pathophysiology
Impaired thymidine synthesis → defective DNA replication
Delayed nuclear maturation
Ineffective hematopoiesis
Intramedullary hemolysis
Pancytopenia (in severe cases)
Vitamin B12 deficiency uniquely affects the nervous system, leading to demyelination (subacute combined degeneration).
Risk Factors
Vitamin B12 Deficiency
Pernicious anemia (autoimmune intrinsic factor deficiency)
Gastrectomy or bariatric surgery
Chronic gastritis
Malabsorption (Crohn’s disease, celiac disease)
Long-term metformin use
Strict vegan diet
Elderly age
Fish tapeworm (Diphyllobothrium latum)
Folate Deficiency
Poor dietary intake
Chronic alcoholism
Pregnancy
Hemolytic anemia (increased demand)
Malabsorption
Methotrexate or anticonvulsant therapy
Signs and Symptoms
General Anemia Features
Pallor
Fatigue
Dyspnea
Tachycardia
Characteristic Features
Mild jaundice (lemon-yellow tint)
Glossitis (beefy red tongue)
Hyperpigmentation of palms
Hair loss
Depression
Weight loss
Neurological Features (Vitamin B12 Deficiency)
Paresthesia (pins and needles)
Numbness (hands and feet)
Ataxic gait
Loss of vibration and position sense
Tremors
Peripheral neuropathy
Cognitive changes
Psychosis (rare)
Neurological symptoms may occur even without severe anemia.
Diagnostic Criteria
Diagnosis is based on:
Macrocytic anemia
Laboratory evidence of B12 or folate deficiency
Characteristic peripheral smear findings
Clinical features
Investigations
Hematological Tests
FBC:
Low hemoglobin
Elevated MCV (>100 fL)
Possible pancytopenia
Reticulocyte count (usually low initially)
Peripheral smear:
Oval macrocytes
Hypersegmented neutrophils (>5 lobes)
Biochemical Tests
Serum vitamin B12
Serum folate
Red cell folate (more reliable)
Elevated LDH
Elevated indirect bilirubin
Homocysteine (↑ in both B12 and folate deficiency)
Methylmalonic acid (↑ only in B12 deficiency)
Additional Tests
TSH (exclude hypothyroidism)
Urea and electrolytes
Liver function tests
Anti-intrinsic factor antibodies (pernicious anemia)
Bone marrow biopsy (if diagnosis unclear)
Differential Diagnosis
Liver disease
Hypothyroidism
Alcoholism
Myelodysplastic syndrome
Aplastic anemia
Drug-induced macrocytosis
Treatment
Treatment depends on the underlying deficiency.
Non-Pharmacological Management
Dietary counseling
Alcohol cessation
Management of malabsorption
Treat underlying gastrointestinal pathology
Pharmacological Management
1. Vitamin B12 Deficiency (Without Neurological Signs)
Hydroxycobalamine (IM) initially 1 mg three times a week for 2 weeks, then 1 mg IM every 3 months.
Review the patient’s blood counts and clinical assessment every 3 months.
2. Pernicious Anemia or B12 Deficiency with Neurological Symptoms
Hydroxycobalamine (IM) initially 1 mg on alternate days until no further improvement is achieved (maximum reversal of neuropsychiatric signs and symptoms), then 1 mg every 2–3 months.
AND
A: Folic acid (PO) 5 mg every 24 hours for at least 3 months. This must be started simultaneously with injectable vitamin B12.
AND
A: Ferrous sulphate (PO) 200 mg every 8 hours for at least 3 months.
Important: Always exclude or treat B12 deficiency before giving folate alone, as folate may correct anemia but worsen neurological damage.
Monitoring Response
Reticulocyte rise within 5–7 days
Hemoglobin improves within 2–3 weeks
Full correction in ~2 months
Neurological recovery may take months
Complications
Irreversible neuropathy (untreated B12 deficiency)
Cognitive impairment
Subacute combined degeneration
Heart failure (severe anemia)
Infertility
Increased thrombotic risk (elevated homocysteine)
Prevention
Balanced diet rich in:
Meat, fish, dairy (B12)
Leafy greens (folate)
Supplementation in:
Pregnancy
Chronic hemolytic anemia
Malabsorption syndromes
Lifelong B12 in pernicious anemia
Screening high-risk elderly patients
Prognosis
Excellent with early treatment
Neurological complications reversible if treated promptly
Pernicious anemia requires lifelong therapy
References
Hoffbrand AV, Moss PAH. Essential Haematology. 8th ed.
Williams Hematology. 10th ed.
British Society for Haematology (BSH). Guidelines on Vitamin B12 and Folate Deficiency.
World Health Organization (WHO). Nutritional Anemias Report.
National Institute for Health and Care Excellence (NICE). Vitamin B12 Deficiency Guidelines.
UpToDate. Clinical manifestations and diagnosis of vitamin B12 and folate deficiency.
Rodak BF. Hematology: Clinical Principles and Applications.
Bain BJ. Blood Cells: A Practical Guide.
Ministry of Health Standard Treatment Guidelines (STG).
O’Leary F, Samman S. Vitamin B12 in health and disease. Nutrients.
Updated on,
